David P. Perry - 09 Feb 2024 Form 4 Insider Report for Better Therapeutics, Inc.

Reporting relationship: Executive Chairman, Director, 10%+ Owner
Issuer ticker: N/A
Reported as of: 09 Feb 2024
Net transaction value: +$160,000
SEC form: 4
Accepted by SEC: 13 Feb 2024, 21:50:33 UTC
Prior SEC filing: 10 Jan 2024
Source filing: View source filing
Reporting owner signature: /s/ Shoaib Ghias, Attorney-in-Fact for David P. Perry

Key filing fact

David P. Perry filed Form 4 for Better Therapeutics, Inc. on 13 Feb 2024.

Key facts

This page summarizes David P. Perry's Form 4 filing for Better Therapeutics, Inc..
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 13 Feb 2024, 21:50.

Change

Previous filing in this sequence was filed on 10 Jan 2024.
Current net transaction value: +$160,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BTTX transaction

Common Stock

Award

Transaction value: $160,000
Shares: +839,895
Change %: +53%
Price: $0.1905
Shares after: 2,416,634
Date: 09 Feb 2024
Ownership: Direct
Footnotes: F1

BTTX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 13,030,393
Date: 09 Feb 2024
Ownership: By Perry Trust
Footnotes: F2

BTTX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 3,636,364
Date: 09 Feb 2024
Ownership: By Maule-Ffinch Trust
Footnotes: F3

BTTX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 293,150
Date: 09 Feb 2024
Ownership: By spouse
Footnotes: F4

BTTX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 21,336
Date: 09 Feb 2024
Ownership: By Pensus Limited Trust
Footnotes: F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

On February 9, 2024, the Issuer entered into a Securities Purchase Agreement with David P. Perry ("Perry") in a private placement offering, pursuant to which Perry agreed to purchase shares of Issuer common stock for $0.1905 per share.

Footnote F2

These shares are owned directly by the David P. Perry 2015 Trust (the "Perry Trust"), a ten percent owner of the Issuer and of which Perry is trustee. Perry disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that Perry is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Footnote F3

These shares are owned directly by the Georgianna Maule-Ffinch 2015 Trust (the "Maule-Ffinch Trust") of which Perry's spouse, Georgianna Maule-Ffinch ("Maule-Ffinch"), is sole trustee, for the benefit of Maule-Ffinch and her children. Perry disclaims beneficial ownership of these securities, and the filing of this Form 4 is not an admission that Perry is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Footnote F4

These shares are owned directly by Maule-Ffinch.

Footnote F5

These shares are owned directly by Doland R. Leo, Trustee of Pensus Limited Trust dated 06/12/2010 FBO Georgianna Maule-Ffinch (the "Pensus Limited Trust") for the benefit of Maule-Ffinch. Perry disclaims beneficial ownership of these securities, and the filing of this Form 4 is not an admission that Perry is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.